Given that they both are in NEURO SCIENCES. That would be a no brainer.
If Biogen paid $70, they'd still be getting Acadia at a $30 - $40 discount for future Nuplazid sales.
Also treating for other neuro related diseases.
Details of yield of coming up
Futures shows pre market ask price of $40
Only when they appear!
Shorts PILED on in March. NOW, they are offsetting in an "orderly" FASHION ACCORDING TO SOME ANALYSTS (look it up). With the lowest PE and some of the LARGEST market share, it will be no wonder as the shares break out to $40 in the next week or two.
$50 very soon!
$45 Price target..............mine is $80